Universal American Corporation (NYSE: UAM) Stock Competitors & Peer Comparison
See UAM's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Plans Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for UAM and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| UAM | $1.75 | +0.00% | 0 | 1.01 | $1.73 | N/A |
| UNH | $407.08 | +0.77% | 369.7B | 24.91 | $16.34 | +2.18% |
| CVS | $95.70 | -0.54% | 122.1B | 12.20 | $7.84 | +2.78% |
| ANTM | $482.58 | +2.71% | 114.6B | 18.99 | $25.41 | +1.42% |
| ELV | $394.20 | +0.76% | 85.5B | 13.41 | $29.39 | +1.74% |
| CI | $282.49 | +2.63% | 74.6B | 9.14 | $30.90 | +2.18% |
| HUM | $385.00 | +4.84% | 46.2B | 24.28 | $15.86 | +0.92% |
| CNC | $65.77 | +2.45% | 32.5B | 26.11 | $2.52 | N/A |
| MOH | $196.45 | +2.38% | 10.3B | 28.39 | $6.92 | N/A |
| OSCR | $27.90 | +5.12% | 7.2B | 19.93 | $1.40 | N/A |
Stock Comparison
UnitedHealth Group Incorporated (NYSE: UNH)
UAM vs UNH Comparison August 2026
Universal American Corporation (NYSE: UAM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UAM stands at 0. In comparison, UNH has a market cap of 369.7B. Regarding current trading prices, UAM is priced at $1.75 on the NYSE, while UNH trades at $407.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UAM currently has a P/E ratio of 1.01, whereas UNH's P/E ratio is 24.91. In terms of profitability, UAM's ROE is +0.17%, compared to UNH's ROE of +0.14%. Regarding short-term risk, UAM is less volatile compared to UNH. This indicates lower risk in terms of short-term price fluctuations for UAM.Check UNH's competition here
CVS Health Corp. (NYSE: CVS)
UAM vs CVS Comparison August 2026
Universal American Corporation (NYSE: UAM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UAM stands at 0. In comparison, CVS has a market cap of 122.1B. Regarding current trading prices, UAM is priced at $1.75 on the NYSE, while CVS trades at $95.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UAM currently has a P/E ratio of 1.01, whereas CVS's P/E ratio is 12.20. In terms of profitability, UAM's ROE is +0.17%, compared to CVS's ROE of +0.06%. Regarding short-term risk, UAM is less volatile compared to CVS. This indicates lower risk in terms of short-term price fluctuations for UAM.Check CVS's competition here
Elevance Health Inc. (NYSE: ANTM)
UAM vs ANTM Comparison August 2026
Universal American Corporation (NYSE: UAM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UAM stands at 0. In comparison, ANTM has a market cap of 114.6B. Regarding current trading prices, UAM is priced at $1.75 on the NYSE, while ANTM trades at $482.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UAM currently has a P/E ratio of 1.01, whereas ANTM's P/E ratio is 18.99. In terms of profitability, UAM's ROE is +0.17%, compared to ANTM's ROE of +0.11%. Regarding short-term risk, UAM is less volatile compared to ANTM. This indicates lower risk in terms of short-term price fluctuations for UAM.Check ANTM's competition here
Elevance Health Inc. (NYSE: ELV)
UAM vs ELV Comparison August 2026
Universal American Corporation (NYSE: UAM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UAM stands at 0. In comparison, ELV has a market cap of 85.5B. Regarding current trading prices, UAM is priced at $1.75 on the NYSE, while ELV trades at $394.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UAM currently has a P/E ratio of 1.01, whereas ELV's P/E ratio is 13.41. In terms of profitability, UAM's ROE is +0.17%, compared to ELV's ROE of +0.11%. Regarding short-term risk, UAM is less volatile compared to ELV. This indicates lower risk in terms of short-term price fluctuations for UAM.Check ELV's competition here
Cigna Corporation (NYSE: CI)
UAM vs CI Comparison August 2026
Universal American Corporation (NYSE: UAM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UAM stands at 0. In comparison, CI has a market cap of 74.6B. Regarding current trading prices, UAM is priced at $1.75 on the NYSE, while CI trades at $282.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UAM currently has a P/E ratio of 1.01, whereas CI's P/E ratio is 9.14. In terms of profitability, UAM's ROE is +0.17%, compared to CI's ROE of +0.15%. Regarding short-term risk, UAM is less volatile compared to CI. This indicates lower risk in terms of short-term price fluctuations for UAM.Check CI's competition here
Humana Inc. (NYSE: HUM)
UAM vs HUM Comparison August 2026
Universal American Corporation (NYSE: UAM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UAM stands at 0. In comparison, HUM has a market cap of 46.2B. Regarding current trading prices, UAM is priced at $1.75 on the NYSE, while HUM trades at $385.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UAM currently has a P/E ratio of 1.01, whereas HUM's P/E ratio is 24.28. In terms of profitability, UAM's ROE is +0.17%, compared to HUM's ROE of +0.07%. Regarding short-term risk, UAM is less volatile compared to HUM. This indicates lower risk in terms of short-term price fluctuations for UAM.Check HUM's competition here
Centene Corp. (NYSE: CNC)
UAM vs CNC Comparison August 2026
Universal American Corporation (NYSE: UAM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UAM stands at 0. In comparison, CNC has a market cap of 32.5B. Regarding current trading prices, UAM is priced at $1.75 on the NYSE, while CNC trades at $65.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UAM currently has a P/E ratio of 1.01, whereas CNC's P/E ratio is 26.11. In terms of profitability, UAM's ROE is +0.17%, compared to CNC's ROE of -0.24%. Regarding short-term risk, UAM is less volatile compared to CNC. This indicates lower risk in terms of short-term price fluctuations for UAM.Check CNC's competition here
Molina Healthcare, Inc. (NYSE: MOH)
UAM vs MOH Comparison August 2026
Universal American Corporation (NYSE: UAM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UAM stands at 0. In comparison, MOH has a market cap of 10.3B. Regarding current trading prices, UAM is priced at $1.75 on the NYSE, while MOH trades at $196.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UAM currently has a P/E ratio of 1.01, whereas MOH's P/E ratio is 28.39. In terms of profitability, UAM's ROE is +0.17%, compared to MOH's ROE of -0.00%. Regarding short-term risk, UAM is less volatile compared to MOH. This indicates lower risk in terms of short-term price fluctuations for UAM.Check MOH's competition here
Oscar Health, Inc. (NYSE: OSCR)
UAM vs OSCR Comparison August 2026
Universal American Corporation (NYSE: UAM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UAM stands at 0. In comparison, OSCR has a market cap of 7.2B. Regarding current trading prices, UAM is priced at $1.75 on the NYSE, while OSCR trades at $27.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UAM currently has a P/E ratio of 1.01, whereas OSCR's P/E ratio is 19.93. In terms of profitability, UAM's ROE is +0.17%, compared to OSCR's ROE of +0.39%. Regarding short-term risk, UAM is less volatile compared to OSCR. This indicates lower risk in terms of short-term price fluctuations for UAM.Check OSCR's competition here
Alignment Healthcare, Inc. (NASDAQ: ALHC)
UAM vs ALHC Comparison August 2026
Universal American Corporation (NYSE: UAM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UAM stands at 0. In comparison, ALHC has a market cap of 3B. Regarding current trading prices, UAM is priced at $1.75 on the NYSE, while ALHC trades at $14.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UAM currently has a P/E ratio of 1.01, whereas ALHC's P/E ratio is 159.67. In terms of profitability, UAM's ROE is +0.17%, compared to ALHC's ROE of +0.20%. Regarding short-term risk, UAM is less volatile compared to ALHC. This indicates lower risk in terms of short-term price fluctuations for UAM.Check ALHC's competition here
Clover Health Investments, Corp. (NASDAQ: CLOV)
UAM vs CLOV Comparison August 2026
Universal American Corporation (NYSE: UAM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UAM stands at 0. In comparison, CLOV has a market cap of 2.5B. Regarding current trading prices, UAM is priced at $1.75 on the NYSE, while CLOV trades at $4.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UAM currently has a P/E ratio of 1.01, whereas CLOV's P/E ratio is 111.63. In terms of profitability, UAM's ROE is +0.17%, compared to CLOV's ROE of -0.05%. Regarding short-term risk, UAM is less volatile compared to CLOV. This indicates lower risk in terms of short-term price fluctuations for UAM.Check CLOV's competition here
Bright Health Group, Inc. (NYSE: BHG)
UAM vs BHG Comparison August 2026
Universal American Corporation (NYSE: UAM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UAM stands at 0. In comparison, BHG has a market cap of 130.5M. Regarding current trading prices, UAM is priced at $1.75 on the NYSE, while BHG trades at $16.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UAM currently has a P/E ratio of 1.01, whereas BHG's P/E ratio is -0.12. In terms of profitability, UAM's ROE is +0.17%, compared to BHG's ROE of +0.04%. Regarding short-term risk, UAM is less volatile compared to BHG. This indicates lower risk in terms of short-term price fluctuations for UAM.Check BHG's competition here
Caring Brands, Inc. (NASDAQ: CABR)
UAM vs CABR Comparison August 2026
Universal American Corporation (NYSE: UAM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UAM stands at 0. In comparison, CABR has a market cap of 12.1M. Regarding current trading prices, UAM is priced at $1.75 on the NYSE, while CABR trades at $1.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UAM currently has a P/E ratio of 1.01, whereas CABR's P/E ratio is -2.38. In terms of profitability, UAM's ROE is +0.17%, compared to CABR's ROE of -3.28%. Regarding short-term risk, UAM is less volatile compared to CABR. This indicates lower risk in terms of short-term price fluctuations for UAM.Check CABR's competition here
Aetna Inc. (NYSE: AET)
UAM vs AET Comparison August 2026
Universal American Corporation (NYSE: UAM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UAM stands at 0. In comparison, AET has a market cap of 0. Regarding current trading prices, UAM is priced at $1.75 on the NYSE, while AET trades at $106.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UAM currently has a P/E ratio of 1.01, whereas AET's P/E ratio is 9.57. In terms of profitability, UAM's ROE is +0.17%, compared to AET's ROE of +0.11%. Regarding short-term risk, UAM is similarly volatile compared to AET. This indicates similar risk in terms of short-term price fluctuations for UAM.Check AET's competition here
Magellan Health, Inc. (NASDAQ: MGLN)
UAM vs MGLN Comparison August 2026
Universal American Corporation (NYSE: UAM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UAM stands at 0. In comparison, MGLN has a market cap of 0. Regarding current trading prices, UAM is priced at $1.75 on the NYSE, while MGLN trades at $94.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UAM currently has a P/E ratio of 1.01, whereas MGLN's P/E ratio is 8.49. In terms of profitability, UAM's ROE is +0.17%, compared to MGLN's ROE of +0.00%. Regarding short-term risk, UAM is similarly volatile compared to MGLN. This indicates similar risk in terms of short-term price fluctuations for UAM.Check MGLN's competition here
Triple-S Management Corporation (NYSE: GTS)
UAM vs GTS Comparison August 2026
Universal American Corporation (NYSE: UAM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UAM stands at 0. In comparison, GTS has a market cap of 0. Regarding current trading prices, UAM is priced at $1.75 on the NYSE, while GTS trades at $35.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UAM currently has a P/E ratio of 1.01, whereas GTS's P/E ratio is 10.41. In terms of profitability, UAM's ROE is +0.17%, compared to GTS's ROE of +0.07%. Regarding short-term risk, UAM is less volatile compared to GTS. This indicates lower risk in terms of short-term price fluctuations for UAM.Check GTS's competition here